by | May 8, 2024 | Publications
Nat Commun. 2024 May 7;15(1):3844. doi: 10.1038/s41467-024-48091-w. ABSTRACT Multiple myeloma (MM) is a heterogeneous disease characterized by frequent MYC translocations. Sporadic MYC activation in the germinal center of genetically engineered Vk*MYC mice is...
by | May 8, 2024 | Publications
Nat Rev Clin Oncol. 2024 May 7. doi: 10.1038/s41571-024-00898-8. Online ahead of print. NO ABSTRACT PMID:38714789 | DOI:10.1038/s41571-024-00898-8
by | May 8, 2024 | Publications
Hemasphere. 2024 May 6;8(5):e76. doi: 10.1002/hem3.76. eCollection 2024 May. ABSTRACT The 2/20/20 International Myeloma Working Group (IMWG) score is the most employed risk score in clinical practice to evaluate the risk of progression from smoldering multiple myeloma...
by | May 8, 2024 | Publications
Zhonghua Xue Ye Xue Za Zhi. 2024 Mar 14;45(3):303-307. doi: 10.3760/cma.j.cn121090-20230915-00123. ABSTRACT Multiple myeloma (MM) is a plasma cell neoplasm characterized by numerous chromosomal number and structural abnormalities, which are of great significance for...
by | May 7, 2024 | Publications
Home Healthc Now. 2024 May-Jun 01;42(3):140-149. doi: 10.1097/NHH.0000000000001249. Epub 2024 May 6. ABSTRACT Multiple myeloma (MM) is a cancer that arises from plasma cells in bone marrow. Approximately 35,730 Americans received a new diagnosis and MM will claim the...
by | May 7, 2024 | Publications
Acta Haematol. 2024 May 6. doi: 10.1159/000539225. Online ahead of print. ABSTRACT BACKGROUND: High-dose therapy (HDT) followed by autologous stem cell transplantation (ASCT) has become part of standard of care (SOC) in newly diagnosed multiple myeloma (MM). In this...
